005: Discovering therapeutic targets in CLL

HIPO Investigator:

Prof. Thorsten Zenz

Dr. Leopold Sellner


Supported by: HIPO/NCT-POP

Entity: CLL


Dietrich S et al. Drug-perturbation-based stratification of blood cancer. J Clin Invest. 2018

Wu B et al.; MED12 mutations and NOTCH signalling in chronic lymphocytic leukaemia; Br J Haematol. 2017

Dietrich S. et al.; BRAF inhibition in hairy cell leukemia with low-dose vemurafenib; Blood 2016

Dietrich S et al.; Recurrent CDKN1B (p27) mutations in hairy cell leukemia; Blood 2015  

Dietrich S et al.; Continued response off treatment after BRAF inhibition in refractory hairy cell leukemia; J Clin Oncol 2013

DKFZ Logo 3zu Research en Black Blue sRGB

4c nctlogo 2009

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
More information Ok Decline